Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose

被引：0
|
作者：
Dickinson, L. [1 ]
Jackson, A. [2 ]
Garvey, L. [3 ]
Watson, V [1 ]
Khoo, S. [1 ]
Winston, A. [3 ]
Boffito, M. [2 ]
Davies, G. [1 ]
Back, D. [1 ]
机构：
[1] Univ Liverpool, Dept Mol & Clin Pharmacol, Pharmacol Res Labs, Liverpool L69 3BX, Merseyside, England
[2] Chelsea & Westminster Fdn Trust, St Stephens Ctr, London, England
[3] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept HIV & GU Med, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷
关键词：
D O I：
10.7448/IAS.15.6.18331
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [41] Efficacy of Lopinavir-Ritonavir Reduced Dose in HIV-Infected Patients
    Lattuada, Emanuela
    Lanzafame, Massimiliano
    Vento, Sandro
    AIDS PATIENT CARE AND STDS, 2011, 25 (08) : 455 - 456
  • [42] Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients
    Justesen, US
    Andersen, ÅB
    Klitgaard, NA
    Brosen, K
    Gerstoft, J
    Pedersen, C
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 426 - 429
  • [43] Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients
    Calcagno, A.
    Nozza, S.
    Simiele, M.
    Milia, M. G.
    Chiappetta, S.
    D'Avolio, A.
    Ghisetti, V.
    Lazzarin, A.
    Di Perri, G.
    Bonora, S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2586 - 2588
  • [44] Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
    Punyawudho, Baralee
    Thammajaruk, Narukjaporn
    Ruxrungtham, Kiat
    Avihingsanon, Anchalee
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (03) : 327 - 332
  • [45] Efficacy and Tolerability of Darunavir/Ritonavir in Combination with Abacavir/Lamivudine: An Option in Selected HIV-Infected Patients
    de los Santos, Ignacio
    Gomez-Berrocal, Ana
    Valencia, Eulalia
    Asensi, Victor
    Gijon, Paloma
    Moreno, Victoria
    Vergas, Jorge
    Bernardino, Ignacio
    HIV CLINICAL TRIALS, 2013, 14 (05): : 254 - 259
  • [46] Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS
    Arathoon, E.
    Schneider, S.
    Baraldi, E.
    Lim, P. L.
    Opravil, M.
    Van De Casteele, T.
    Lavreys, L.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2013, 24 (01) : 12 - 17
  • [47] Effect of Efavirenz, Nevirapine, Etravirine, and Raltegravir Administration on the Pharmacokinetics of Ritonavir-Boosted Darunavir in a Population of HIV-Infected Patients
    Dailly, Eric
    Allavena, Clotilde
    Bouquie, Regis
    Deslandes, Guillaume
    Raffi, Francois
    Jolliet, Pascale
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (01) : 42 - 46
  • [48] Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy
    Calza, Leonardo
    Cafaggi, Matteo
    Colangeli, Vincenzo
    Borderi, Marco
    Barchi, Enrico
    Lanzafame, Massimiliano
    Nicole', Stefano
    Degli Antoni, Anna Maria
    Bon, Isabella
    Re, Maria Carla
    Viale, Pierluigi
    INFECTIOUS DISEASES, 2018, 50 (05) : 352 - 360
  • [49] Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
    Conradie, F.
    Zorrilla, C.
    Josipovic, D.
    Botes, M.
    Osiyemi, O.
    Vandeloise, E.
    Eley, T.
    Child, M.
    Bertz, R.
    Hu, W.
    Wirtz, V.
    McGrath, D.
    HIV MEDICINE, 2011, 12 (09) : 570 - 579
  • [50] Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients
    Singkham, Noppaket
    Avihingsanon, Anchalee
    Brundage, Richard C.
    Birnbaum, Angela K.
    Thammajaruk, Narukjaporn
    Ruxrungtham, Kiat
    Bunupuradah, Torsak
    Kiertiburanakul, Sasisopin
    Chetchotisakd, Ploenchan
    Punyawudho, Baralee
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (01) : 99 - 108
12345